
<head>
<style>
.card {
  /* Add shadows to create the "card" effect */
  box-shadow: 0 4px 8px 0 rgba(0,0,0,0.2);
  transition: 0.3s;
  padding-left: 20px;
  padding-right: 20px;
  padding-top: 10px;
  padding-bottom: 10px;

}

.card-query {
    background: #EEEEFF;
    box-shadow: 0 0px 8px 0 rgba(0,0,0,0.2);
}

.button {
  background-color: #EEEEEE;
  border: none;
  color: black;
  padding: 15px 32px;
  text-align: center;
  text-decoration: none;
  display: inline-block;
  font-size: 16px;
}

</style>
</head>
<body style="margin-left: 10%; margin-right: 10%; padding-top: 70px;">
<div class="card card-query"><h2>Query: disease models for infection, disease and transmission</h2><br /></div><br /><br /><br /><div class="card"><h3>Monkeypox Virus Infections in Small Animal Models for Evaluation of Anti-Poxvirus Agents</h3>
<p style="text-align: justify; text-justify: inter-word;">An ideal animal model for the study of a human disease is one which utilizes a route of infection that mimics the natural transmission of the pathogen; the ability to obtain disease with an infectious dose equivalent to that causing disease in humans; as well having a disease course, morbidity and mortality similar to that seen with human disease.</p>
<p align="right"><i>score: 111</i></p>

</div><br /><br /><br /><div class="card"><h3>Behavioural change models for infectious disease transmission: a systematic review (2010-2015)</h3>
<p style="text-align: justify; text-justify: inter-word;">We review behavioural change models (BCMs) for infectious disease transmission in humans. Following the Cochrane collaboration guidelines and the PRISMA statement, our systematic search and selection yielded 178 papers covering the period 2010-2015. We observe an increasing trend in published BCMs, frequently coupled to (re)emergence events, and propose a categorization by distinguishing how information translates into preventive actions. Behaviour is usually captured by introducing information as a dynamic parameter (76/178) or by introducing an economic objective function, either with (26/178) or without (37/178) imitation. Approaches using information thresholds (29/178) and exogenous behaviour formation (16/178) are also popular. We further classify according to disease, prevention measure, transmission model (with 81/178 population, 6/178 metapopulation and 91/178 individuallevel models) and the way prevention impacts transmission. We highlight the minority (15%) of studies that use any real-life data for parametrization or validation and note that BCMs increasingly use social media data and generally incorporate multiple sources of information (16/178), multiple types of information (17/178) or both (9/178). We conclude that individual-level models are increasingly used and useful to model behaviour changes. Despite recent advancements, we remain concerned that most models are purely theoretical and lack representative data and a validation process.</p>
<p align="right"><i>score: 105</i></p>

</div><br /><br /><br /><div class="card"><h3>Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset</h3>
<p style="text-align: justify; text-justify: inter-word;">The availability of a robust disease model is essential for the development of countermeasures for Middle East respiratory syndrome coronavirus (MERS-CoV). While a rhesus macaque model of MERS-CoV has been established, the lack of uniform, severe disease in this model complicates the analysis of countermeasure studies. Modeling of the interaction between the MERS-CoV spike glycoprotein and its receptor dipeptidyl peptidase 4 predicted comparable interaction energies in common marmosets and humans. The suitability of the marmoset as a MERS-CoV model was tested by inoculation via combined intratracheal, intranasal, oral and ocular routes. Most of the marmosets developed a progressive severe pneumonia leading to euthanasia of some animals. Extensive lesions were evident in the lungs of all animals necropsied at different time points post inoculation. Some animals were also viremic; high viral loads were detected in the lungs of all infected animals, and total RNAseq demonstrated the induction of immune and inflammatory pathways. This is the first description of a severe, partially lethal, disease model of MERS-CoV, and as such will have a major impact on the ability to assess the efficacy of vaccines and treatment strategies as well as allowing more detailed pathogenesis studies.</p>
<p align="right"><i>score: 101</i></p>

</div><br /><br /><br /><div class="card"><h3>The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters</h3>
<p style="text-align: justify; text-justify: inter-word;">In 2012 a novel coronavirus, MERS-CoV, associated with severe respiratory disease emerged in the Arabian Peninsula. To date, 55 human cases have been reported, including 31 fatal cases. Several of the cases were likely a result of human-to-human transmission. The emergence of this novel coronavirus prompts the need for a small animal model to study the pathogenesis of this virus and to test the efficacy of potential intervention strategies. In this study we explored the use of Syrian hamsters as a small animal disease model, using intratracheal inoculation and inoculation via aerosol. Clinical signs of disease, virus replication, histological lesions, cytokine upregulation nor seroconversion were observed in any of the inoculated animals, indicating that MERS-CoV does not replicate in Syrian hamsters. Citation: de Wit E, Prescott J, Baseler L, Bushmaker T, Thomas T, et al. (2013) The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters. PLoS ONE 8(7): e69127.</p>
<p align="right"><i>score: 96</i></p>

</div><br /><br /><br /><div class="card"><h3>Stochastic challenges to interrupting helminth transmission</h3>
<p style="text-align: justify; text-justify: inter-word;">Predicting the effect of different programmes designed to control both the morbidity induced by helminth infections and parasite transmission is greatly facilitated by the use of mathematical models of transmission and control impact. In such models, it is essential to account for as many sources of uncertainty-natural, or otherwise -to ensure robustness in prediction and to accurately depict variation around an expected outcome. In this paper, we investigate how well the standard deterministic models match the predictions made using individual-based stochastic simulations. We also explore how well concepts which derive from deterministic models, such as 'breakpoints' in transmission, apply in the stochastic world. Employing an individual based stochastic model framework we also investigate how transmission and control are affected by the migration of infected people into a defined community. To give our study focus we consider the control of soil-transmitted helminths (STH) by mass drug administration (MDA), though our methodology is readily applicable to the other helminth species such as the schistosome parasites and the filarial worms. We show it is possible to define a 'stochastic breakpoint' where much noise surrounds the expected deterministic breakpoint. We also discuss the concept of the 'interruption of transmission' independent of the 'breakpoint' concept where analyses of model behaviour illustrate the current limitations of deterministic models to account for the 'fade-out' or transmission extinction behaviour in simulations. The analyses based on migration confirm a relationship between the infected human migration rate per unit of time and the death rate of infective stages that are released into the free-living environment (eggs or larvae depending on the STH species) that create the reservoir of infection which in turn determines the likelihood that control activities aim at chemotherapeutic treatment of the human host will eliminate transmission. The development of a new stochastic simulation code for STH in the form of a publicly-available open-source python package which includes features to incorporate many population stratifications, different control interventions including mass drug administration (with defined frequency, coverage levels and compliance patterns) and inter-village human migration is also described. : medRxiv preprint</p>
<p align="right"><i>score: 88</i></p>

</div><br /><br /><br /><div class="card"><h3>Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study</h3>
<p style="text-align: justify; text-justify: inter-word;">Results: A significant fraction of MERS cases were linked to the healthcare setting, ranging from 43.5 % for the nosocomial outbreak in Jeddah, Saudi Arabia, in 2014 to 100 % for both the outbreak in Al-Hasa, Saudi Arabia, in 2013 and the outbreak in South Korea in 2015. Both MERS and SARS nosocomial outbreaks are characterized by early nosocomial super-spreading events, with the reproduction number dropping below 1 within three to five disease generations. There was a systematic difference in the exposure patterns of MERS and SARS: a majority of MERS cases occurred among patients who sought care in the same facilities as the index case, whereas there was a greater concentration of SARS cases among healthcare workers throughout the outbreak. Exposure patterns differed slightly by disease generation, however, especially for SARS. Moreover, the distributions of secondary cases per single primary case varied highly across individual hospital outbreaks (Kruskal-Wallis test; P < 0.0001), with significantly higher transmission heterogeneity in the distribution of secondary cases for MERS than SARS. Simulations indicate a 2-fold higher probability of occurrence of large outbreaks (>100 cases) for SARS than MERS (2 % versus 1 %); however, owing to higher transmission heterogeneity, the largest outbreaks of MERS are characterized by sharper incidence peaks. The probability of occurrence of MERS outbreaks larger than the South Korean cluster (n = 186) is of the order of 1 %.</p>
<p align="right"><i>score: 87</i></p>

</div><br /><br /><br /><div class="card"><h3>Attenuation of influenza A virus disease severity by viral co-infection in a mouse model 2 3 Short Title: Pathogenesis of influenza viral co-infection 4 5</h3>
<p style="text-align: justify; text-justify: inter-word;">disease severity and that they may also interfere with each other's spread within a host population.</p>
<p align="right"><i>score: 85</i></p>

</div><br /><br /><br /><div class="card"><h3>A quantitative narrative on movement, disease and patch exploitation in nesting agent groups</h3>
<p style="text-align: justify; text-justify: inter-word;">27 Systems approaches to modeling disease limit our ability to consider individual-level 28 traits, unless these traits can be reasonably well expressed by dividing the population 29 into a limited number of subgroups, such as groups of individuals infected with different 30 strains of pathogens [29]. Including individual-level variation in disease models, however, 31 requires an agent-based approach [30], which then allows both individual behavior (e.g., 32 relevant to evaluating the probability of pathogen transmission) and pathogen exposure 33 history (e.g., relevant to evaluating the immunological state and hence the susceptibility 34 of an individual) to be incorporated into the model. It also allows one to trace the 35 number of individuals the each pathogen infects [25] and, hence, to identify individuals 36 that may be acting as super-spreaders [31].</p>
<p align="right"><i>score: 84</i></p>

</div><br /><br /><br /><div class="card"><h3>Port d'Entr√©e for Respiratory Infections -Does the Influenza A Virus Pave the Way for Bacteria?</h3>
<p style="text-align: justify; text-justify: inter-word;">Bacterial and viral co-infections of the respiratory tract are life-threatening and present a global burden to the global community. Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes are frequent colonizers of the upper respiratory tract. Imbalances through acquisition of seasonal viruses, e.g., Influenza A virus, can lead to bacterial dissemination to the lower respiratory tract, which in turn can result in severe pneumonia. In this review, we summarize the current knowledge about bacterial and viral co-infections of the respiratory tract and focus on potential experimental models suitable for mimicking this disease. Transmission of IAV and pneumonia is mainly modeled by mouse infection. Few studies utilizing ferrets, rats, guinea pigs, rabbits, and non-human primates are also available. The knowledge gained from these studies led to important discoveries and advances in understanding these infectious diseases. Nevertheless, mouse and other infection models have limitations, especially in translation of the discoveries to humans. Here, we suggest the use of human engineered lung tissue, human ex vivo lung tissue, and porcine models to study respiratory co-infections, which might contribute to a greater translation of the results to humans and improve both, animal and human health.</p>
<p align="right"><i>score: 84</i></p>

</div><br /><br /><br /><div class="card"><h3>Integration of shared-pathogen networks and machine learning reveals the key aspects of zoonoses and predicts mammalian reservoirs</h3>
<p style="text-align: justify; text-justify: inter-word;">Diseases that spread to humans from animals, zoonoses, pose major threats to human health. Identifying animal reservoirs of zoonoses and predicting future outbreaks are increasingly important to human health and well-being and economic stability, particularly where research and resources are limited. Here, we integrate complex networks and machine learning approaches to develop a new approach to identifying reservoirs. An exhaustive dataset of mammal-pathogen interactions was transformed into networks where hosts are linked via their shared pathogens. We present a methodology for identifying important and influential hosts in these networks. Ensemble models linking network characteristics with phylogeny and life-history traits are then employed to predict those key hosts and quantify the roles they undertake in pathogen transmission. Our models reveal drivers explaining host importance and demonstrate how these drivers vary by pathogen taxa. Host importance is further integrated into ensemble models to predict reservoirs of zoonoses of various pathogen taxa and quantify the extent of pathogen sharing between humans and mammals. We establish predictors of reservoirs of zoonoses, showcasing host influence to be a key factor in determining these reservoirs. Finally, we provide new insight into the determinants of zoonosis-sharing, and contrast these determinants across major pathogen taxa.</p>
<p align="right"><i>score: 84</i></p>

</div><br /><br /><br /><div class="card"><h3>Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling</h3>
<p style="text-align: justify; text-justify: inter-word;">Viral infectious diseases are a global health concern, as is evident by recent outbreaks of the middle east respiratory syndrome, Ebola virus disease, and re-emerging zika, dengue, and chikungunya fevers. Viral epidemics are a socio-economic burden that causes short-and long-term costs for disease diagnosis and treatment as well as a loss in productivity by absenteeism. These outbreaks and their socio-economic costs underline the necessity for a precise analysis of virus-host interactions, which would help to understand disease mechanisms and to develop therapeutic interventions. The combination of quantitative measurements and dynamic mathematical modeling has increased our understanding of the within-host infection dynamics and has led to important insights into viral pathogenesis, transmission, and disease progression. Furthermore, virus-host models helped to identify drug targets, to predict the treatment duration to achieve cure, and to reduce treatment costs. In this article, we review important achievements made by mathematical modeling of viral kinetics on the extracellular, intracellular, and multi-scale level for Human Immunodeficiency Virus, Hepatitis C Virus, Influenza A Virus, Ebola Virus, Dengue Virus, and Zika Virus. Herein, we focus on basic mathematical models on the population scale (so-called target cell-limited models), detailed models regarding the most important steps in the viral life cycle, and the combination of both. For this purpose, we review how mathematical modeling of viral dynamics helped to understand the virus-host interactions and disease progression or clearance. Additionally, we review different types and effects of therapeutic strategies and how mathematical modeling has been used to predict new treatment regimens.</p>
<p align="right"><i>score: 83</i></p>

</div><br /><br /><br /><div class="card"><h3>The Spatial Resolution of Epidemic Peaks</h3>
<p style="text-align: justify; text-justify: inter-word;">The emergence of novel respiratory pathogens can challenge the capacity of key health care resources, such as intensive care units, that are constrained to serve only specific geographical populations. An ability to predict the magnitude and timing of peak incidence at the scale of a single large population would help to accurately assess the value of interventions designed to reduce that peak. However, current disease-dynamic theory does not provide a clear understanding of the relationship between: epidemic trajectories at the scale of interest (e.g. city); population mobility; and higher resolution spatial effects (e.g. transmission within small neighbourhoods). Here, we used a spatially-explicit stochastic meta-population model of arbitrary spatial resolution to determine the effect of resolution on model-derived epidemic trajectories. We simulated an influenza-like pathogen spreading across theoretical and actual population densities and varied our assumptions about mobility using Latin-Hypercube sampling. Even though, by design, cumulative attack rates were the same for all resolutions and mobilities, peak incidences were different. Clear thresholds existed for all tested populations, such that models with resolutions lower than the threshold substantially overestimated population-wide peak incidence. The effect of resolution was most important in populations which were of lower density and lower mobility. With the expectation of accurate spatial incidence datasets in the near future, our objective was to provide a framework for how to use these data correctly in a spatial meta-population model. Our results suggest that there is a fundamental spatial resolution for any pathogen-population pair. If underlying interactions between pathogens and spatially heterogeneous populations are represented at this resolution or higher, accurate predictions of peak incidence for city-scale epidemics are feasible.</p>
<p align="right"><i>score: 82</i></p>

</div><br /><br /><br /><div class="card"><h3>Implications of Host Genetic Variation on the Risk and Prevalence of Infectious Diseases Transmitted Through the Environment</h3>
<p style="text-align: justify; text-justify: inter-word;">Previous studies have shown that host genetic heterogeneity in the response to infectious challenge can affect the emergence risk and the severity of diseases transmitted through direct contact between individuals. However, there is substantial uncertainty about the degree and direction of influence owing to different definitions of genetic variation, most of which are not in line with the current understanding of the genetic architecture of disease traits. Also, the relevance of previous results for diseases transmitted through environmental sources is unclear. In this article a compartmental genetic-epidemiological model was developed to quantify the impact of host genetic diversity on epidemiological characteristics of diseases transmitted through a contaminated environment. The model was parameterized for footrot in sheep. Genetic variation was defined through continuous distributions with varying shape and degree of dispersion for different disease traits. The model predicts a strong impact of genetic heterogeneity on the disease risk and its progression and severity, as well as on observable host phenotypes, when dispersion in key epidemiological parameters is high. The impact of host variation depends on the disease trait for which variation occurs and on environmental conditions affecting pathogen survival. In particular, compared to homogeneous populations with the same average susceptibility, disease risk and severity are substantially higher in populations containing a large proportion of highly susceptible individuals, and the differences are strongest when environmental contamination is low. The implications of our results for the recording and analysis of disease data and for predicting response to selection are discussed.</p>
<p align="right"><i>score: 82</i></p>

</div><br /><br /><br /><div class="card"><h3>Robustness of the reproductive number estimates in vector-borne disease systems Supplementary material Individual Based Model</h3>
<p style="text-align: justify; text-justify: inter-word;">Initially, a disease-free stochastic individual based model for the hosts and vectors of the virus was constructed with no spatial component, and time t discretized into days. Daily, individual humans and vectors were aged, and terminated if their age exceeded their life expectancy. Only the adult stage of a vector's life cycle was considered, since only adult vectors generally acquire and transmit the vector-borne disease. We assumed age-dependent mortalities for both the hosts and the vectors. For both the host and vector, this is governed a Weibull distribution.</p>
<p align="right"><i>score: 81</i></p>

</div><br /><br /><br /><div class="card"><h3>A quantitative narrative on movement, disease and patch exploitation in nesting agent groups</h3>
<p style="text-align: justify; text-justify: inter-word;">Here, we develop an agent-based formulation that has application to studying 38 disease outbreaks in wildlife populations whose state of health-and hence, 39 susceptibility-is impacted by various factors, including social factors related to group 40 living and the structure of social networks [32], ecological factors related to foraging 41 success, and the movement behavior of individuals (which influences exposure to 42 pathogens). The model also includes a periodic return to a colony or nest cell, which 43 implies that the model has both a population-level and a group-association level (core 44 or household) structure. Such models have applications in animal production systems 45 (e.g., managing foot and mouth disease [33]), wildlife conservation [2], and disease 46 management at the human-animal interface [34]. The latter involves diseases such as 47 anthrax [35], bovine tuberculosis [36], and brucellosis in cattle and wild ungulates [37], 48 chronic wasting disease in deer [38], and toxoplasmosis in rats, cats and humans [39]. 49 Rather then following a formulaic ODD (Overview, Design concepts, and Design 50 details; [30, 40]) or extended ODD [41] prescription in presenting our model, we take a 51 more expository approach by first crafting a broad outline of our model's general 52 October 1, 2019 2/28 All rights reserved. No reuse allowed without permission.</p>
<p align="right"><i>score: 80</i></p>

</div><br /><br /><br /><div class="card"><h3>Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study</h3>
<p style="text-align: justify; text-justify: inter-word;">Miniopterus schreibersii bat species in Catalonia. We find that persistence relies on host spatial structure through the migratory nature of M. schreibersii, on cross-species mixing with M. myotis, and on survival of infected animals followed by temporary immunity. The virus would not persist in the single colony of M. myotis. Our study provides for the first time epidemiological estimates for EBLV-1 progression in M. schreibersii. Our approach can be readily adapted to other zoonoses of public health concern where long-range migration and habitat sharing may play an important role.</p>
<p align="right"><i>score: 79</i></p>

</div><br /><br /><br /><div class="card"><h3>Bayesian uncertainty quantification for transmissibility of influenza, norovirus and Ebola using information geometry</h3>
<p style="text-align: justify; text-justify: inter-word;">Infectious diseases exert a large and in many contexts growing burden on human health, but violate most of the assumptions of classical epidemiological statistics and hence require a mathematically sophisticated approach. Viral shedding data are collected during human studies-either where volunteers are infected with a disease or where existing cases are recruited-in which the levels of live virus produced over time are measured. These have traditionally been difficult to analyse due to strong, complex correlations between parameters. Here, we show how a Bayesian approach to the inverse problem together with modern Markov chain Monte Carlo algorithms based on information geometry can overcome these difficulties and yield insights into the disease dynamics of two of the most prevalent human pathogens-influenza and norovirus-as well as Ebola virus disease.</p>
<p align="right"><i>score: 79</i></p>

</div><br /><br /><br /><div class="card"><h3>The battle against SARS and MERS coronaviruses: Reservoirs and Animal Models</h3>
<p style="text-align: justify; text-justify: inter-word;">animal models, coronaviruses, reservoirs, the Middle East respiratory syndrome (canonical form), the severe acute respiratory syndrome</p>
<p align="right"><i>score: 79</i></p>

</div><br /><br /><br /><div class="card"><h3>Individual and temporal variation in pathogen load predicts long- 1 term impacts of an emerging infectious disease</h3>
<p style="text-align: justify; text-justify: inter-word;">Tasmanian devil populations. This is because strong population declines of devils after 45 disease emergence do not necessarily translate into long-term population declines at 46 equilibria. Our modelling approach is widely applicable to other host-pathogen systems to 47 predict disease impact beyond transient dynamics.</p>
<p align="right"><i>score: 78</i></p>

</div><br /><br /><br /><div class="card"><h3>Transmission of rhinovirus in the Utah BIG- LoVE families: Consequences of age and household structure</h3>
<p style="text-align: justify; text-justify: inter-word;">Acquisition of HRV was less probable in older individuals and those infected with a coronavirus, and higher with a higher proportion of other household members infected. Loss of HRV is reduced with a higher proportion of other household members infected. Within households, only children and symptomatic individuals show evidence for transmission, while between households only a higher number of infected older children (ages 5-19) increases the probability of acquisition. Coronaviruses, paramyxoviruses and bocavirus also show evidence of intrahousehold transmission. Simulations show that age-dependent susceptibility and transmission have the largest effects on mean HRV prevalence.</p>
<p align="right"><i>score: 78</i></p>

</div><br /><br /><br /></body>